Influence of preoperative combined radiochemotherapy on surgical outcome and colonic anastomotic healing: experimental study in the rat

Int J Radiat Oncol Biol Phys. 2001 Jul 15;50(4):1073-8. doi: 10.1016/s0360-3016(01)01600-5.

Abstract

Purpose: To study the influence of combined preoperative hyperfractionated irradiation with intraperitoneal 5-fluorouracil (5-FU) on surgical outcome and colonic anastomotic healing in a rat model.

Methods: Male Wistar rats were given 41.6 Gy of preoperative radiotherapy (RT) or sham irradiation, with intraperitoneal 5-FU at low dose (10 mg/kg) or high dose (20 mg/kg). Animals were arranged in 6 groups: RT + low-dose 5-FU (RCT-L), RT + high-dose 5-FU (RCT-H), sham RT + low-dose 5-FU (CT-L), sham RT + high-dose 5-FU (CT-H), RT alone (R), and a control group (sham RT + intraperitoneal saline). Side-to-side colonic anastomoses were constructed from one irradiated and one nonirradiated limb 4 days after radiochemotherapy. Animals were sacrificed 10 days after surgery.

Results: Compared to controls, more complications occurred in group RCT-H (50% versus 0%, p = 0.01). Adhesion formation was more intense in groups RCT-H and CT-H (p < 0.001 and p = 0.001, respectively). After therapy, white blood cell counts dropped significantly in all irradiated animals (p < 0.01), and platelet counts decreased significantly in group RCT-H (p = 0.01). No significant differences were noticed in anastomotic bursting pressure when the treated groups were compared to each other or to the control group.

Conclusions: Neoadjuvant radiochemotherapy has no adverse effect on the strength of colonic anastomosis in this rat model. However, the combined RT with high-dose 5-FU does increase operative morbidity and adhesion formation.

MeSH terms

  • Anastomosis, Surgical
  • Animals
  • Antimetabolites, Antineoplastic / therapeutic use*
  • Blood Cell Count
  • Colon / drug effects*
  • Colon / radiation effects*
  • Colon / surgery
  • Combined Modality Therapy
  • Dose Fractionation, Radiation
  • Fluorouracil / therapeutic use*
  • Infusions, Parenteral
  • Male
  • Rats
  • Rats, Wistar
  • Serum Albumin / analysis
  • Tissue Adhesions
  • Wound Healing

Substances

  • Antimetabolites, Antineoplastic
  • Serum Albumin
  • Fluorouracil